Supernus Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SUPN and other ETFs, options, and stocks.About SUPN
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products.
CEOJack A. Khattar
CEOJack A. Khattar
Employees674
Employees674
HeadquartersRockville, Maryland
HeadquartersRockville, Maryland
Founded2005
Founded2005
Employees674
Employees674
SUPN Key Statistics
Market cap2.57B
Market cap2.57B
Price-Earnings ratio-132.31
Price-Earnings ratio-132.31
Dividend yield—
Dividend yield—
Average volume1.39M
Average volume1.39M
High today$45.73
High today$45.73
Low today$44.05
Low today$44.05
Open price$45.11
Open price$45.11
Volume810.56K
Volume810.56K
52 Week high$57.65
52 Week high$57.65
52 Week low$29.16
52 Week low$29.16
Stock Snapshot
Supernus Pharmaceuticals(SUPN) stock is priced at $44.90, giving the company a market capitalization of 2.57B. It carries a P/E multiple of -132.31.
On 2025-11-18, Supernus Pharmaceuticals(SUPN) stock moved within a range of $44.05 to $45.73. With shares now at $44.90, the stock is trading +1.9% above its intraday low and -1.8% below the session's peak.
Trading activity shows a volume of 810.56K, compared to an average daily volume of 1.39M.
Over the past 52 weeks, Supernus Pharmaceuticals(SUPN) stock has traded between a high of $57.65 and a low of $29.16.
Over the past 52 weeks, Supernus Pharmaceuticals(SUPN) stock has traded between a high of $57.65 and a low of $29.16.
Analyst ratings
83%
of 6 ratingsBuy
83.3%
Hold
16.7%
Sell
0%
People also own
Based on the portfolios of people who own SUPN. This list is generated using Robinhood data, and it’s not a recommendation.